Replication competent helper functions for recombinant AAV vector generation
Open Access
- 1 September 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 9 (18), 1199-1206
- https://doi.org/10.1038/sj.gt.3301710
Abstract
Adeno-associated virus (AAV) is a promising gene transfer vector tested in both animal studies and human clinical trials. However, current production methods are generally inefficient and require improvements to meet the increasing clinical need for economical, high titer and high quality rAAV vectors. The inefficiency of the current systems largely arises from the AAV helper function, which contains only the AAV coding region but lacks inverted terminal repeats. The terminal repeats were originally removed to prevent replication competent AAV contamination. Here we designed a novel and highly efficient rAAV helper function containing AAV terminal repeats. The new helper function not only mimics the wild-type AAV growth as it replicates along with the vector plasmid, but also restores the cis regulating function of the AAV terminal repeats. Addition of heterologous introns to the helper genome and use of a mutant AAV terminal repeat defective in packaging effectively controls the contamination of replication competent AAV particles. This new strategy also performs better in AAV producing cell lines than those based on non-replicating AAV rep and cap genome.Keywords
This publication has 33 references indexed in Scilit:
- Characterization of Adenovirus-Induced Inverted Terminal Repeat-Independent Amplification of Integrated Adeno-Associated Virus rep-cap SequencesJournal of Virology, 2001
- Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genomeThe Journal of Gene Medicine, 2000
- High-Titer Recombinant Adeno-Associated Virus Production from Replicating Amplicons and Herpes Vectors Deleted for Glycoprotein HHuman Gene Therapy, 1999
- High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and CapGene Therapy, 1999
- Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirusGene Therapy, 1999
- High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle VirusHuman Gene Therapy, 1998
- Factors Influencing Recombinant Adeno-Associated Virus ProductionHuman Gene Therapy, 1998
- Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1996
- Cell Lines for the Production of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1995
- Rescue and Replication Signals of the Adeno-associated Virus 2 GenomeJournal of Molecular Biology, 1995